文献速递冠心病

冠状动脉内血栓的成像技术

Imaging of intracoronary thrombus.
PubMed 文献 · Heart · 2023-04-25

本文综述了冠状动脉内血栓与动脉粥样硬化血栓形成的成像方法。有创冠状动脉造影仍是心肌梗死评估的主要手段,血管镜、IVUS和OCT可提高血栓检测敏感性。CT和MRI等无创技术结合PET及特异性放射性示踪剂有望实现无创血栓检测,但尚未常规应用。

要点

  • 有创冠状动脉造影是心肌梗死评估的主要成像方式。
  • 血管镜、IVUS和OCT可作为辅助手段提高血栓检测敏感性。
  • CT/MRI结合PET及血小板、纤维蛋白等示踪剂有望无创检测血栓。

核心结论

  • 识别冠状动脉内血栓和动脉粥样硬化血栓形成对急性心肌梗死诊断至关重要,区分1型和2型心肌梗死直接影响患者管理。
  • 有创血管内成像可提高血栓检测敏感性,但受实际和后勤限制难以常规广泛应用。
  • 无创技术结合PET和特异性放射性示踪剂有望实现冠状动脉内血栓的无创检测,但尚未在常规临床实践中实现。

研究设计与样本

  • 综述性文章,未报告系统检索范围或样本量。

主要发现

  • 有创冠状动脉造影仍是心肌梗死患者评估的主要成像方式。
  • 血管镜、血管内超声和光学相干断层扫描可提供冠状动脉粥样硬化斑块和心肌梗死病因的更直接可视化,并提高血栓检测的敏感性。
  • CT和MRI等无创血管成像技术已更广泛可用,改善了冠状动脉疾病的无创可视化,但可靠识别冠状动脉内血栓的能力有限。
  • 将CT/MRI对冠状动脉解剖的结构表征与PET结合,可克服无创技术识别血栓能力有限的问题。
  • 与血栓成分(如活化血小板、纤维蛋白和因子XIIIa)高特异性、高敏感性结合的放射性示踪剂,有望用于冠状动脉内血栓的无创检测。

临床怎么用

  • 临床诊断急性心肌梗死时需识别冠状动脉内血栓并区分1型和2型心肌梗死以指导即刻患者管理。
  • 有创冠状动脉造影作为主要成像方式,必要时可辅以血管镜、IVUS或OCT提高血栓检测敏感性。
  • 无创CT/MRI结合PET及特异性放射性示踪剂目前尚未常规用于临床检测冠状动脉内血栓。

局限性

  • 有创血管内成像方法存在实际和后勤限制,妨碍其广泛常规应用。
  • CT和MRI可靠识别冠状动脉内血栓的能力有限。
  • 新型无创方法尚未在常规临床实践中实现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The identification of intracoronary thrombus and atherothrombosis is central to the diagnosis of acute myocardial infarction, with the differentiation between type 1 and type 2 myocardial infarction being crucial for immediate patient management. Invasive coronary angiography has remained the principal imaging modality used in the investigation of patients with myocardial infarction. More recently developed invasive intravascular imaging approaches, such as angioscopy, intravascular ultrasound and optical coherence tomography, can be used as adjunctive imaging modalities to provide more direct visualisation of coronary atheroma and the causes of myocardial infarction as well as to improve the sensitivity of thrombus detection. However, these invasive approaches have practical and logistic constraints that limit their widespread and routine application. Non-invasive angiographic techniques, such as CT and MRI, have become more widely available and have improved the non-invasive visualisation of coronary artery disease. Although they also have a limited ability to reliably identify intracoronary thrombus, this can be overcome by combining their anatomical and structural characterisation of coronary anatomy with positron emission tomography. Specific radiotracers which bind with high specificity and sensitivity to components of thrombus, such as activated platelets, fibrin and factor XIIIa, hold promise for the non-invasive detection of intracoronary thrombus. The development of these novel non-invasive approaches has the potential to inform clinical decision making and patient management as well as to provide a non-invasive technique to assess the efficacy of novel antithrombotic therapies or interventional strategies. However, these have yet to be realised in routine clinical practice.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Whittington B, Tzolos E, Williams MC, et al. Imaging of intracoronary thrombus. Heart. 2023. PMID: 36549679. doi:10.1136/heartjnl-2022-321361

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。